Apogepha Arzneimittel GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1882-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.apogepha.de
Clinical Trials
13
Active:8
Completed:3
Trial Phases
4 Phases
Phase 1:2
Phase 2:1
Phase 3:3
+1 more phases
Drug Approvals
5
NMPA:5
Drug Approvals
Propiverine Hydrochloride Modified Release Capsules
- Product Name
- 迈通诺
- Approval Number
- 国药准字HJ20170173
- Approval Date
- Nov 12, 2024
NMPA
Propiverine Hydrochloride Modified Release Capsules
- Product Name
- 迈通诺
- Approval Number
- 国药准字HJ20140799
- Approval Date
- Nov 12, 2024
NMPA
Propiverine Hydrochloride Modified Release Capsules
- Product Name
- 迈通诺
- Approval Number
- 国药准字J20171031
- Approval Date
- Jun 16, 2020
NMPA
Propiverine Hydrochloride Modified Release Capsules
- Product Name
- 迈通诺
- Approval Number
- H20170173
- Approval Date
- Apr 13, 2020
NMPA
Propiverine Hydrochloride Modified Release Capsules
- Product Name
- 迈通诺
- Approval Number
- H20140799
- Approval Date
- Nov 15, 2019
NMPA
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 3
3 (42.9%)Phase 1
2 (28.6%)Not Applicable
1 (14.3%)Phase 2
1 (14.3%)Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity
Phase 3
Completed
- Conditions
- Neurogenic Urinary Bladder DisorderUrinary Bladder, NeurogenicBladder Disorder, NeurogenicUrinary Bladder Disorder, NeurogenicNeurogenic Bladder DisorderUrinary Bladder Neurogenic DysfunctionUrologic DiseasesOveractive Detrusor FunctionUrinary Incontinence
- Interventions
- First Posted Date
- 2012-02-10
- Last Posted Date
- 2012-02-10
- Lead Sponsor
- APOGEPHA Arzneimittel GmbH
- Target Recruit Count
- 66
- Registration Number
- NCT01530620
Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder
- First Posted Date
- 2008-11-21
- Last Posted Date
- 2008-11-21
- Lead Sponsor
- APOGEPHA Arzneimittel GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT00795925
Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence
Phase 3
Completed
- Conditions
- Overactive BladderUrinary IncontinenceChildren
- Interventions
- Drug: Mictonetten 5 mg, coated tabletDrug: placebo
- First Posted Date
- 2008-01-29
- Last Posted Date
- 2008-01-29
- Lead Sponsor
- APOGEPHA Arzneimittel GmbH
- Target Recruit Count
- 303
- Registration Number
- NCT00603343
News
No news found